Pharmacovigilance plays a vital role in monitoring drug safety, minimizing adverse drug reactions (ADRs), and promoting the significance of reporting such events within healthcare systems. This study aimed to investigate the challenges and perspectives of pharmacists in Duhok, particularly those working in hospital and community pharmacy settings, regarding pharmacovigilance and ADR reporting. A cross-sectional survey was conducted from February 20 to March 20 2019 using a self-administered questionnaire that had been pre-designed and refined. Data analysis was performed using SPSS version 20. Most participating pharmacists recognized their responsibility in reporting ADRs and emphasized the importance of drug safety monitoring (91%). Over 85% agreed that ADRs causing life-threatening events or congenital abnormalities require immediate reporting. Despite this, the majority lacked awareness of the Iraqi pharmacovigilance system, had never submitted ADR reports, faced difficulties accessing reporting forms, and possessed insufficient clinical knowledge to identify ADRs. The primary issue highlighted by this study was underreporting, as most respondents could not accurately define “pharmacovigilance,” even though they understood ADRs and maintained a positive attitude toward reporting. Enhancing pharmacists’ knowledge and awareness through targeted interventional programs is essential to improve ADR reporting practices.
